Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

798
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
798
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma.

European journal of cancer (Oxford, England : 1990)·2026
Same author

EBV-associated histological transformation of marginal zone lymphomas: two case reports and a literature review.

Virchows Archiv : an international journal of pathology·2026
Same author

Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph<sup>+</sup> Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Pediatric blood & cancer·2026
Same author

Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocol.

International journal of hematology·2026
Same author

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

British journal of haematology·2026
Same author

Integrated genetic analyses identified T-cell neoplasms other than adult T-cell leukemia/lymphoma in HTLV-1 carriers.

Blood advances·2025

Related Experiment Video

Updated: Jan 6, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.7K

[Precision medicine in hematological malignancies].

Takahiko Yasuda1, Keizo Horibe1

  • 1Nagoya Medical Center, Clinical Research Center.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|October 11, 2019
PubMed
Summary

Precision medicine uses genetic profiling to improve cancer treatment efficiency. This study examines its clinical utility in hematological malignancies and suggests future development strategies.

Keywords:
Clinical sequenceExpert panelHematological malignanciesPotentially actionable finding

More Related Videos

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.3K

Related Experiment Videos

Last Updated: Jan 6, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.7K
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

1.9K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.3K

Area of Science:

  • Oncology
  • Genetics
  • Pharmacogenomics

Background:

  • Cancer is a leading cause of death in Japan, driving the need for advanced treatments.
  • Precision medicine, utilizing genetic profiling, aims to optimize therapeutic benefits for specific patient groups.
  • The Japanese government is launching a national cancer genome medicine initiative.

Purpose of the Study:

  • To provide an overview of the clinical utility of precision medicine in hematological malignancies.
  • To discuss the future development of precision medicine in this field.
  • To share insights from a feasibility study on clinical sequencing in blood cancers.

Main Methods:

  • Review of clinical utility data for precision medicine in hematological malignancies.
  • Analysis of findings from a feasibility study involving clinical sequencing.
  • Discussion of strategic development pathways for precision medicine in hematological cancers.

Main Results:

  • Precision medicine demonstrates significant potential for enhancing treatment outcomes in hematological malignancies.
  • Clinical sequencing feasibility studies provide valuable data for guiding future research and application.
  • The integration of genetic profiling is crucial for tailoring treatments to individual patients.

Conclusions:

  • Precision medicine offers a promising approach to personalize cancer care, particularly in hematological malignancies.
  • Further development and implementation of clinical sequencing are essential for advancing precision oncology.
  • Strategic planning based on feasibility studies will accelerate the adoption of precision medicine in Japan.